|
Atypical Vascular Lesion |
Postradiation Angiosarcoma, Low-Grade Histology |
Age |
Middle age and older women (usually sixth decade) |
Women over 50 y of age (approximately 20 y older than women with primary angiosarcoma), time to diagnosis ranges from 2.5 to 11.5 y (median 4.5 y) after radiation therapy; risk of developing postradiation angiosaroma is approximately 0.3% |
Location |
Breast skin |
Breast skin, may extend into adjacent mammary parenchyma |
Presentation |
Papules or plaques appearing several years (average 3-4 y) following radiation therapy; red-brown or pink |
Multifocal, cutaneous, purple-blue and erythematous plaques, papules, or nodules within the radiation field which may secondarily involve adjacent breast parenchyma |
Imaging findings |
Skin thickening; none |
None or skin thickening; associated ill-defined density with involvement of breast parenchyma; magnetic resonance imaging (MRI) may be useful in defining the size |
Etiology |
Radiation exposure, usually for breast cancer |
Radiation treatment for breast cancer |
Histology |
Localized, often wedge-shaped collection of haphazardly arranged and focally dilated vascular spaces in dermis. May be very subtle (Fig. 10.3.1)
Vascular spaces may have a complex branching pattern and be anastomosing (Figs. 10.3.2 and 10.3.3)
The vascular spaces are confined to the dermis and lined by a single layer of plump endothelial cells with nuclear hobnailing and hyperchromasia, but no mitoses (Fig. 10.3.4)
Vascular spaces separated by small bundles of dermal collagen
Vessels suggest an infiltrative process; however, overall small size and circumscription support a diagnosis of atypical vascular lesion
|
Complex, anastomosing vascular channels that infiltrate the dermis and/or the breast parenchyma (Figs. 10.3.5 and 10.3.6)
Well-defined vascular spaces lined by cells with prominent nuclei that protrude into the vascular lumen (Figs. 10.3.7 and 10.3.8)
Subtle permeation of adipose tissue mimics angiolipoma
May contain atypical vascular lesion-like areas in the periphery of the lesion; distinction from atypical vascular lesion on core biopsy specimen may be difficult, requiring excision for diagnosis
|
Special studies |
Absent c-myc expression by immunohistochemistry and lack of myc amplification by fluorescence in situ hybridization (FISH) distinguish from angiosarcoma with high specificity; immunohistochemistry for ERG may reassure a limited extent of the process and circumscription but does not distinguish from angiosarcoma. Immunohistochemical staining for vascular markers does not distinguish from angiosarcoma. |
MYC amplification present in >50% of postradiation angiosarcomas but absent in atypical vascular lesions. Immunohistochemistry for c-myc shows nearly 100% concordance with MYC amplification as detected by FISH. Immunohistochemical expression of vascular markers does not distinguish from atypical vascular lesions. |
Treatment |
Atypical vascular lesions should be excised with the aim of obtaining negative margins. When diagnosed on needle core biopsy, excision is generally warranted to exclude angiosarcoma. |
Total mastectomy; wide excision alone is associated with high recurrence rates. Radiotherapy and chemotherapy ineffective. |
Clinical implication |
Following complete excision, the majority pursue a benign clinical course with a few cases reportedly recurring locally or progressing to angiosarcoma. Distinction from angiosarcoma is critical to avoid excessive surgery and inappropriate prognostication. |
Postradiation angiosarcoma, regardless of grade, has a poor prognosis with a mean survival of 1-2 y |